Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 77

1.

Reconstruction of wave front and object for inline holography from a set of detection planes.

Hagemann J, Robisch AL, Luke DR, Homann C, Hohage T, Cloetens P, Suhonen H, Salditt T.

Opt Express. 2014 May 19;22(10):11552-69. doi: 10.1364/OE.22.011552.

PMID:
24921276
[PubMed - in process]
2.

Invasive Aspergillus infections in hospitalized patients with chronic lung disease.

Wessolossky M, Welch VL, Sen A, Babu TM, Luke DR.

Infect Drug Resist. 2013 May 27;6:33-9. doi: 10.2147/IDR.S43069. Print 2013.

PMID:
23761976
[PubMed]
Free PMC Article
3.

Discovery of Dap-3 polymyxin analogues for the treatment of multidrug-resistant Gram-negative nosocomial infections.

Magee TV, Brown MF, Starr JT, Ackley DC, Abramite JA, Aubrecht J, Butler A, Crandon JL, Dib-Hajj F, Flanagan ME, Granskog K, Hardink JR, Huband MD, Irvine R, Kuhn M, Leach KL, Li B, Lin J, Luke DR, MacVane SH, Miller AA, McCurdy S, McKim JM Jr, Nicolau DP, Nguyen TT, Noe MC, O'Donnell JP, Seibel SB, Shen Y, Stepan AF, Tomaras AP, Wilga PC, Zhang L, Xu J, Chen JM.

J Med Chem. 2013 Jun 27;56(12):5079-93. doi: 10.1021/jm400416u. Epub 2013 Jun 18.

PMID:
23735048
[PubMed - indexed for MEDLINE]
4.

Evaluation of intravenous voriconazole in patients with compromised renal function.

Lilly CM, Welch VL, Mayer T, Ranauro P, Meisner J, Luke DR.

BMC Infect Dis. 2013 Jan 16;13:14. doi: 10.1186/1471-2334-13-14.

PMID:
23320795
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Pharmacokinetics of sulfobutylether-β-cyclodextrin (SBECD) in subjects on hemodialysis.

Luke DR, Wood ND, Tomaszewski KE, Damle B.

Nephrol Dial Transplant. 2012 Mar;27(3):1207-12. doi: 10.1093/ndt/gfr472. Epub 2011 Aug 24.

PMID:
21868395
[PubMed - indexed for MEDLINE]
Free Article
6.

Review of the basic and clinical pharmacology of sulfobutylether-beta-cyclodextrin (SBECD).

Luke DR, Tomaszewski K, Damle B, Schlamm HT.

J Pharm Sci. 2010 Aug;99(8):3291-301. doi: 10.1002/jps.22109. Review.

PMID:
20213839
[PubMed - indexed for MEDLINE]
7.

Prospective observational study of patient-reported outcomes for azithromycin versus usual care in the treatment of bacterial acute exacerbation of chronic bronchitis.

Milstone A, Patsimas J, Farzan D, Castaldo R, Singh H, Feurer I, Harnett J, Luke DR; PROPeR Use Study Group.

Clin Ther. 2005 Jun;27(6):926-39.

PMID:
16117993
[PubMed - indexed for MEDLINE]
8.

Hybrid projection-reflection method for phase retrieval.

Bauschke HH, Combettes PL, Luke DR.

J Opt Soc Am A Opt Image Sci Vis. 2003 Jun;20(6):1025-34.

PMID:
12801170
[PubMed]
9.

Phase retrieval, error reduction algorithm, and Fienup variants: a view from convex optimization.

Bauschke HH, Combettes PL, Luke DR.

J Opt Soc Am A Opt Image Sci Vis. 2002 Jul;19(7):1334-45.

PMID:
12095200
[PubMed]
11.

Treatment of acute gynecologic infections with trovafloxacin. Trovafloxacin Surgical Group.

Roy S, Koltun W, Chatwani A, Martens MG, Dittrich R, Luke DR.

Am J Surg. 1998 Dec;176(6A Suppl):67S-73S.

PMID:
9935260
[PubMed - indexed for MEDLINE]
12.

Trovafloxacin in the treatment of intra-abdominal infections: results of a double-blind, multicenter comparison with imipenem/cilastatin. Trovafloxacin Surgical Group.

Donahue PE, Smith DL, Yellin AE, Mintz SJ, Bur F, Luke DR.

Am J Surg. 1998 Dec;176(6A Suppl):53S-61S.

PMID:
9935258
[PubMed - indexed for MEDLINE]
13.

Double-blind comparison of single-dose alatrofloxacin and cefotetan as prophylaxis of infection following elective colorectal surgery. Trovafloxacin Surgical Group.

Milsom JW, Smith DL, Corman ML, Howerton RA, Yellin AE, Luke DR.

Am J Surg. 1998 Dec;176(6A Suppl):46S-52S.

PMID:
9935257
[PubMed - indexed for MEDLINE]
14.

Role of neutrophils and macrophages in experimental nephrosis of the rat.

Berens KL, Verani RR, Luke DR.

Ren Fail. 1998 Jan;20(1):53-63.

PMID:
9509560
[PubMed - indexed for MEDLINE]
15.

Pharmacokinetics of azithromycin after single- and multiple-doses in children.

Stevens RC, Reed MD, Shenep JL, Baker DK, Foulds G, Luke DR, Blumer JL, Rodman JH.

Pharmacotherapy. 1997 Sep-Oct;17(5):874-80.

PMID:
9324176
[PubMed - indexed for MEDLINE]
16.

Toleration of intravenous azithromycin.

Luke DR, Foulds G.

Ann Pharmacother. 1997 Sep;31(9):965-9.

PMID:
9296232
[PubMed - indexed for MEDLINE]
17.

Disposition of oral azithromycin in humans.

Luke DR, Foulds G.

Clin Pharmacol Ther. 1997 Jun;61(6):641-8.

PMID:
9209246
[PubMed - indexed for MEDLINE]
18.

Safety, toleration, and pharmacokinetics of intravenous azithromycin.

Luke DR, Foulds G, Cohen SF, Levy B.

Antimicrob Agents Chemother. 1996 Nov;40(11):2577-81.

PMID:
8913468
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

The absence of an effect of food on the bioavailability of azithromycin administered as tablets, sachet or suspension.

Foulds G, Luke DR, Teng R, Willavize SA, Friedman H, Curatolo WJ.

J Antimicrob Chemother. 1996 Jun;37 Suppl C:37-44.

PMID:
8818844
[PubMed - indexed for MEDLINE]
Free Article
20.

Pharmacokinetics of azithromycin in pediatric patients with acute otitis media.

Nahata MC, Koranyi KI, Luke DR, Foulds G.

Antimicrob Agents Chemother. 1995 Aug;39(8):1875-7.

PMID:
7486938
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk